We observed that compared to wild type cancers, p53 mutant melanomas show greatly reduced p53 signaling (Figure 1F) and reduced mRNA expression of the key p53 target gene p21 (CDKN1A, Figure 1G). The gene discussed is CDKN1A; the disease is melanoma.